| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IGMS | Common Stock | Award | $11.2K | +960 | +0.7% | $11.71 | 139K | May 15, 2023 | Direct | F1 |
| transaction | IGMS | Common Stock | Sale | -$11.9K | -970 | -0.7% | $12.30 | 138K | May 23, 2023 | Direct | F2, F3 |
| transaction | IGMS | Common Stock | Sale | -$156 | -12 | -0.01% | $13.01 | 138K | May 23, 2023 | Direct | F2, F4 |
| holding | IGMS | Common Stock | 1.01K | May 23, 2023 | See footnote | F5 |
| Id | Content |
|---|---|
| F1 | The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| F2 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
| F3 | This transaction was executed in multiple trades at prices ranging from $12.00 to $12.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F4 | This transaction was executed in multiple trades at prices ranging from $13.00 to $13.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F5 | The shares are held directly by the Reporting Person's spouse. |